Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
This chart shows which pharmaceutical companies received the most new drug approvals last year.
The drug companies with the most new drugs last year are Gilead Sciences Inc, Ucb Inc, Abbvie Inc, Acadia Pharms Inc, Accord Hlthcare, Allergan Inc, Avanir Pharms, Avedro Inc, Bristol-myers Squibb, and Collegium Pharm Inc.